Fig. 2: Ranking probabilities base on the multiple comparisons on ORR, PFS and OS in network meta-analysis.

Ranking probabilities on ORR (a), PFS (b), and OS (c) in NSCLC patients with a high PD-L1 expression according to multiple comparisons. ICI immune checkpoint inhibitors, chemo-ICI ICI-combined chemotherapy.